TNW

INmune Bio and Quantum Computing partner to apply quantum optimization and AI to advance Alzheimer

Boca Raton, Florida, October 14th, 2026, Financewire Collaboration combines INmune Bios clinical research with QCis Dirac-3S quantum optimization machine to identify potential new treatment indications and biomarkers for XPro. Initial engagement marks QCis first commercial customer in pharmaceutical and biotechnology markets, expanding the application of quantum computing to drug development. INmune Bio Inc. (Nasdaq: INMB) [] This story continues at The Next Web